Halaven® (eribulin mesylate)

Halaven® is typically utilized in the treatment of patients with metastatic breast cancer who have received at least two chemotherapy regimens.

For indications, dosing and other information, please refer to the prescribing information.

Halaven® ‐ Eisai

Size:
1 mg, 2 mL SDV
NDC #:
62856-0389-01
Download:
PI